Death on dialysis and the time/flux trade-off

Blood Purification

Volumn 15, Issue 1, 1997, Pages 1-14

  Henderson, L W ^a   Leypoldt, J K ^b   Lysaght, M J ^c   Cheung, A K ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UREA;

EDITORIAL; HEMODIALYSIS; KIDNEY CLEARANCE; KIDNEY FAILURE; PRIORITY JOURNAL;

CONVECTION; DIFFUSION; FEMALE; HEMOFILTRATION; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UREA;

EID: 0030928857     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170312     Document Type: Article

References (44)

1. Charra B. Calcmard E. RuITcl M. Chazot C, Terrát JC, Vancl T. Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-1291.
2. Scribner BH: Comment. Trans Am Soc Artif Intern Organs 1965; 11:29.
3. Colton CK, Lvsaght MJ: Membranes for hemodialysis; in Jacobs C. Kjcllstrand CM. Koch KM. Winchester J F (eds): Replacement of Renal Function by Dialysis, ed 4. Dordrecht. Kluwer Academic. 1996, pp 103-113.
4. Keshaviah P: Implications of the urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int 1993:43(suppl 40):28-38.
5. Held PJ., Brunner F., Odaka M., Garcia JR., Port FK., Gaylin DS: Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan. 1982 and 1987. Am J Kidney Dis 1990:15:451-457.
6. Held PJ., Blagg CR., Liska DW., Port FK., Hakim R., Levin N: The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int 1992: 42(suppl 38): 16-21.
7. Held PJ. Carroll CE. Liska DW. Turcnnc MN. Port FK: Hemodialysis therapy in the United Slates: What is the dose and does it matter? Am J Kidney Dis 1994:24:974-980.
8. Held PJ. Levin NW. Bovbjerg RR. Pauly MV. Diamond LH: Mortality and duration of hemodialysis. JAMA 1991:265:871-875.
9. I ienderson LW: Dialysis; in Coe FL, Curtis JJ, Favus MJ, Henderson L. Kashgarian M. Luke R. Meyers B (eds): Yearbook of Nephrology. Chicago. Mosby. 1996. pp 173-246.
10. Khan IH. Calto GRD. Edward N. MacLeod AM: Death during the First 90 days of dialysis: A case control study. Am J Kidney Dis 1995; 25:276-280.
11. Eadington DW, Craig KJ, Winney RJ: Late referral for RRT: Still a common cause of avoidable morbidity (abstract). Nephrol Dial Transpl 1994:9:1686.
12. RalclilTe PJ. Phillips RE. Oliver DO: Late referral for maintenance dialysis. BrMedJ 1984:288:441.
13. Tattersall J. Greenwood R. Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 1995:15:283-289.
14. European Dialysis and Transplanta-tion Association. Wing AJ (Chairman): Combined Report on Regular Dialysis and Transplantation in Europe. 19th Proc EDTA. 1981. p 50.
15. Parker TF. Laird NM. Lowrie EG: Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int 1983;23(suppl 13): 42-49.
16. Laird NM, Berkcy CS, Lowrie EG: Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 1983;23(suppl 13): 101-106.
17. Henderson LW: Of time. TAC and treatment schedules. Kidney Int 1988;(suppl 24): 105-106.
18. Churchill DN. Taylor W. Keshaviah PR: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996:7: 198-207.
19. Keshaviah PR, Nolph KD., Van Stone JC: The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Per-it Dial Int 1989:9:257-260.
20. Babb AL, Johansen PJ. Strand MJ. Tenckhoff H, Scribner BFL: Bidirectional permeability of the human peritoneum to middle molecules. EDTA Proc 1973:10:247-257.
21. Henderson I.W: The problem of peritoneal membrane area and permeability. Kidney Int 1973:3:409-410.
22. Leypoldt JK. Parker HR, Frigon RP, Henderson LW: Molecular sized dependence of peritoneal transport. J Lab Clin Med 1987,110: 207-216.
23. Popovich RP. Moncrief JW. Nolph KD. Ghods AJ. Twardowski ZJ. Pyle WK: Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978:88:449-456.
24. Henderson LW, Nolpli KD: Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.J Clin Invest 1969;48:992-1001.
25. Lysaghl MJ, Pollock CA, Hallct MD. Ibcls LS. Farrell PC: The relevance of urea kinetic modeling to CAPD. Trans Am Soc Artif Intern Organs 1989:35:784-790.
26. Gotch FA. Keen ML: Kinetic modeling in peritoneal dialysis; in Nis-senson AR. Fine AR, Gentile DE (eds): Clinical Dialysis, ed 3. Norwalk, Appleton & Lange. 1995. pp 343-375.
27. Depner TA: Quantifying hemodialysis and peritoneal dialysis: Examination of the peak concentration hypothesis. Semin Dial 1994:7:315-317.
28. Henderson LW: Why do we use clearance? Blood Purif 1995:13: 283-288.
29. Keshaviah P: The solute removal index: A unified basis for comparing disparate therapies. Peril Dial Ini 1995:15:101-104.
30. Durand PY, Chanliau J., Gambcroni J, Mallie J., Kessler M: Urea and creatinine weekly clearance measured by direct quantification: Comparison in APD. CAPD and conventional HD (abstract). Peril Dial Bull 1996:16(suppl): 16-22.
31. Keshaviah PR. Star RA: A r.cw approach to dialysis quantification: An adequacy index based on solute removal. Semin Dial 1994;7:85-90.
32. Chen TW, Huang TP, Liu MC. Wang ML: The removal index for evaluation of dialysis. Peril Dial Int 1996:16:128-134.
33. Qucllhorst EA, Schucnemann B, Hildebrand U: Morbidity and mortality in long-term hemofiltration. ASAIOJ 1983;6:185-191.
34. McKanc WS, Tattcrsall JE, Farrington K: Preservation of residual renal function in high-flux haemodialysis (abstract). Nephrol Dial Trans 1984; 9:1686.
35. Lysaght M. Vonesh EF. Gotch F. Ibcls K. Keen M. Lindholm B. Nolpli KD. Pollock CA. Prowant B. Farrell PC: The influence of dialysis treatment modality on the decline of remaining renal function. Trans Am Soc Artif Intern Organs 1991:37: 598-604.
36. Schreiner GF: Renal toxicity of albumin and other lipoproteins. Curr Opin Nephrol Hvpertens 1995:4: 369-373.
37. Cheung AK. Parker CJ. Wilcox LA. Janatova J: Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophanc. Kidney Int 1990; 37:1055-1059.
38. Qucllhosrt EA. Schuenemann B. Mietzsch G: Long term hemofiltration in 'poor risk' patients. ASAIO.J 1987;10:758-764.
39. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990:38: 487-494.
40. Gutierrez A, Bergstrom J, Alvc-strand A: Protein catabolism in sham-hemodialysis: The effect of different membranes. Clin Nephrol 1992:38:20-29.
41. Borah MF. Shoenfeld P. Gotch FA. etal: Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978:14:491-500.
42. Farrell PC. Hone PW: Dialysis-induced catabolism. Am J Clin Nutr 1980:33:1417-1422.
43. Leypoldt JK. Cheung AK. Carroll CE, Stannard D. Pereira B. Agadoa L, Port F: Removal of middle molecules enhances survival in hemodialysis patients (abstract).J Am Soc Nephrol 1996:7:1454.
44. Held PJ. Port FK. Wolfe RA, Stannard DC. Carroll CE, Daugirdas JT. Bloembcrgen WE. Greer JW. Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 1996;50:550-556.